|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 CAD | 0.00% |
|
0.00% | 0.00% |
| 01-26 | Optimind Pharma Reaches Agreement On Debenture Conversion | MT |
| 01-10 | Optimind Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023 | CI |
Optimind Pharma Corp. reported earnings results for the first quarter ended May 31, 2023. For the first quarter, the company reported sales was CAD 0.041273 million compared to CAD 0.039997 million a year ago.
Net loss was CAD 0.40366 million compared to CAD 0.128495 million a year ago. Basic loss per share from continuing operations was CAD 0.004 compared to CAD 0.002 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 361K | |
| +8.05% | 113B | |
| +10.29% | 106B | |
| +0.41% | 22.27B | |
| -12.06% | 22.22B | |
| -5.99% | 19.43B | |
| -37.36% | 17.87B | |
| -5.74% | 17.24B | |
| +7.23% | 14.29B | |
| +36.63% | 12.52B |
OPTIMIND PHARMA CORP. 
